In adults with peripheral arterial disease, a directional atherectomy system significantly reduced vessel stenosis and plaque burden vs. an orbital atherectomy system, even after drug-coated balloon ...
Please provide your email address to receive an email when new articles are posted on . DeRubertis and colleagues enrolled 102 patients (mean age, 70 years; 66% men) with femoropopliteal lesions 8 cm ...
VIVA Physician Sponsored Study to Determine the Benefits of Debulking Plaque and Maximizing Luminal Gain Prior to Drug Coated Balloon Therapy DUBLIN and LAS VEGAS., Medtronic plc announced today the ...
Largest directional atherectomy study with independent, core lab analysis demonstrates high limb salvage in patients with critical limb ischemia and strong patency rates in both diabetic and ...
Medtronic Plc MDT has initiated a voluntary recall to customers related to the risk associated with tip damage caused by guidewire prolapse in its 6 French (6Fr) TurboHawk Plus Directional Atherectomy ...
Medtronic has recalled 686 TurboHawk Plus Directional Atherectomy Systems because there is a risk that the guidewire within the catheter may move downward or prolapse during use, which may damage the ...
The FDA announced a class I recall of the Medtronic Hawk One directional atherectomy catheter system due to more than 160 reports of problems with the device’s guidewire. The catheter tip could break ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback